Teladoc Health, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Revenue | $233.3M | $123.2M | $77.4M | $43.5M | $19.9M |
| Cost of Revenue | $61.6M | $32.0M | $21.0M | $9.9M | $4.2M |
| Gross Profit | $171.7M | $91.2M | $56.3M | $33.6M | $15.7M |
| Gross Margin | 73.6% | 74.0% | 72.8% | 77.2% | 79.0% |
| Operating Expenses | |||||
| Research & Development | $34.5M | $21.8M | $14.2M | $7.6M | $3.5M |
| SG&A Expense | $79.8M | $48.6M | $43.0M | $17.7M | $8.8M |
| Operating Income | $-75.4M | $-62.7M | $-55.8M | $-15.2M | $-5.9M |
| Operating Margin | -32.3% | -50.9% | -72.1% | -34.8% | -29.5% |
| Interest Expense | — | — | — | — | — |
| Pretax Income | $-107.0M | $-73.7M | $-58.0M | $-16.6M | $-5.9M |
| Income Tax Expense | $-225.0K | $510.0K | $36.0K | $388.0K | $94.0K |
| Net Income | $-106.8M | $-74.2M | $-58.0M | $-17.0M | $-6.0M |
| Net Margin | -45.8% | -60.3% | -75.0% | -39.1% | -30.2% |
| EPS (Basic) | $-1.93 | $-1.75 | $-2.91 | $-10.25 | $-8.05 |
| EPS (Diluted) | $-1.93 | $-1.75 | $-2.91 | $-10.25 | $-8.05 |
| Shares Outstanding (Basic) | 61.5M | 46.2M | 38.5M | 2.0M | — |
| Shares Outstanding (Diluted) | 61.5M | 46.2M | 38.5M | 2.0M | — |
| Dividends Per Share | — | — | — | — | — |